Capital Research Global Investors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105M Buy
4,399,329
+805,753
+22% +$15.5M 0.01% 304
2026
Q1
$63.3M Buy
+3,593,576
New +$72.2M 0.01% 341
2022
Q1
Sell
-900,000
Closed -$12.7M 441
2021
Q4
$12.7M Sell
900,000
-489,096
-35% -$8.57M ﹤0.01% 419
2021
Q3
$22.2M Sell
1,389,096
-360,904
-21% -$6.97M 0.01% 408
2021
Q2
$40.9M Hold
1,750,000
0.01% 382
2021
Q1
$38.4M Buy
+1,750,000
New +$34.2M 0.01% 376

Other funds holding ALHC

Capital Research Global Investors's ALHC Position: Q2 2026 in Review

Capital Research Global Investors increased its Alignment Healthcare (ALHC) stake by 22% in Q2 2026, buying an estimated $15.5M and bringing the position to 4,399,329 shares worth $105M. The position accounts for 0.01% of the portfolio, ranked #304.

Capital Research Global Investors first reported a position in ALHC in Q1 2021 and has held it in 6 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Capital Research Global Investors held 4,399,329 shares of Alignment Healthcare worth $105M as of Q2 2026.
  • Capital Research Global Investors bought 805,753 Alignment Healthcare shares in Q2 2026, an estimated $15.5M.
  • Alignment Healthcare made up 0.01% of Capital Research Global Investors's portfolio in Q2 2026, its #304 holding.
  • Capital Research Global Investors first reported a position in Alignment Healthcare in Q1 2021 and has held it in 6 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.